Search Results - "CHANG, A. Y. C"

Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin by Qazi, R, Chang, A Y, Borch, R F, Montine, T, Dedon, P, Loughner, J, Bennett, J M

“…Diethyldithiocarbamate (DDTC) has been shown to provide protection against most clinically significant toxic effects from cisplatin (DDP) without inhibiting…”
Get more information

A Randomized Placebo-Controlled Trial of Recombinant Human Interleukin-11 in Cancer Patients With Severe Thrombocytopenia Due To Chemotherapy by Tepler, Isidore, Elias, Laurence, Smith, John W., Hussein, Mohamad, Rosen, Gerald, Chang, Alex Y.-C., Moore, Joseph O., Gordon, Michael S., Kuca, Bernice, Beach, Kathleen J., Loewy, John W., Garnick, Marc B., Kaye, James A.

“…Thrombocytopenia is a complication of cancer treatment that can limit dose intensity. Interleukin-11 (IL-11) is a growth factor that increases platelet…”
Get full text

Engineering a Human Bone Marrow Model: A Case Study on ex Vivo Erythropoiesis by Mantalaris, Athanassios, Keng, Peter, Bourne, Patricia, Chang, Alex Y. C., Wu, J. H. David

“…Bone marrow, with its intricate, three‐dimensional tissue structure facilitating cell−cell interactions, provides a microenvironment supporting the production…”
Get full text

Pharmacokinetics of intrapericardial administration of 5-fluorouracil by LERNER-TUNG, M. B, CHANG, A. Y. C, ONG, L. S, KREISER, D

“…A 30-year-old patient with metastatic breast adenocarcinoma was diagnosed as having a malignant pericardial effusion. The patient was treated with two courses…”
Get full text

Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle by CHANG, A. Y. C, KENG, P. C

“…Radiation sensitivity of human hypernephroma tumor cells, ACHN, was evaluated in the presence or absence of various recombinant interferons (IFNs): alpha D…”
Get full text

Optical properties of free-standing silicon quantum wires by SANDERS, G. D, YIA-CHUNG CHANG

“…We present theoretical studies of the optical properties of free-standing Si quantum wires, using an empirical tight-binding model which includes d orbitals…”
Get full text

Phase II study of ifosfamide, carboplatin, and etoposide in patients with advanced non-small cell lung cancer by Hsieh, R K, Chang, A Y, Boros, L, Asbury, R

“…This study was to define the efficacy of ifosfamide, mesna, carboplatin, and etoposide (ICE) in patients with metastatic non-small cell lung cancer (NSCLC)…”
Get more information

Aclacinomycin A and Etoposide (VP-16-213): An Effective Regimen in Previously Treated Patients With Refractory Acute Myelogenous Leukemia by Rowe, Jacob M., Chang, Alex Y.C., Bennett, John M.

“…Thirty-five patients with acute myelogenous leukemia were treated with aclacinomycin A (60 mg/m2/day for 5 days) and VP-16-213 (100 mg/m2/day for 5 days). All…”
Get full text

Initiation of pro-opiomelanocortin mRNA from a normally quiescent promoter in a human small cell lung cancer cell line by Chang, A C, Israel, A, Gazdar, A, Cohen, S N

“…We describe the characteristics of pro-opiomelanocortin (POMC) mRNA synthesized by a human small cell lung cancer (SCLC) cell line that secretes a peptide…”
Get more information

A putative AP-2 binding site in the 5' flanking region of the mouse POMC gene by Bishop, John F., Rinaudo, Mario S., Ritter, Joseph K., Chang, Annie C.-Y., Conant, Katherine, Gehlert, Donald R.

“…Using extracts of AtT-20 cell nuclei, protein binding sites on the POMC gene 5'-flanking region were examined with an exonuclease protection approach. One such…”
Get full text

Treatment of refractory acute leukaemia with aclacinomycin A by Rowe, J M, Chang, A Y, Bennett, J M

Get more information

Adrenal insufficiency. A rare initial sign of metastatic colon carcinoma by Omoigui, N A, Cave, Jr, W T, Chang, A Y

“…A 75-year-old woman evaluated for "drop attacks" 3 years after anterior resection for colo-rectal cancer developed hyponatremia associated with a morning…”
Get more information

A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma by Chang, A Y, Bennett, J M, Pandya, K J, Asbury, R, McCune, C

“…We have studied aminoglutethemide (AG) combined with hydrocortisone in 28 patients with advanced and refractory prostate carcinoma. All the patients had failed…”
Get more information

Microwave active filters based on coupled negative resistance method by Chang, C.-Y., Itoh, T.

“…A novel coupled negative resistance method for building a microwave active bandpass filter is introduced. Based on this method, four microstrip line…”
Get full text

Theory of gain in quantum-wire lasers growth in V-grooves by Citrin, D S, CHANG, Y I A-C H U N G

“…The study presents theoretical calculations of gain, refractive index change, differential gain, and threshold current for GaAs-AlGaAs quantum-wire lasers…”
Get full text

Nasopharyngeal carcinoma in young patients by Chang, A Y, Su, S W, Zen, S H, Wang, W C

“…We have reviewed retrospectively the records of 157 patients, less than or equal to 30 years of age with nasopharyngeal carcinoma (NPC) from 218 such cases…”
Get more information

Normal incidence intersubband optical transition in GaSb/InAs superlattices by CHEN, H. H, HOUNG, M. P, WANG, Y. H, YIA-CHUNG CHANG

“…A novel intersubband optical transition, incorporating interband and p-type intersubband optical transition mechanisms, in a suitably designed GaSb/InAs…”
Get full text

Age as a Risk Factor for Inadequate Treatment by Eshleman, M., O'Shea, J., Cyran, E., Smith, J. L., Chang, A. Y. C., Pandya, K. J.

Get full text

Anisotropy of optical phonons in GaAs-AlAs superlattices by Ren, SF, Chu, H, Chang, YC

“…Phonon dispersion curves of GaAs-AlAs superlattices for various propagation directions are investigated on the basis of a detailed microscopic model that…”
Get full text

Refractory acute lymphocytic leukemia: response to aclacinomycin A and VP-16-213 by Rowe, J M, Chang, A Y, Bennett, J M

“…Twelve patients with acute lymphoblastic leukemia (ALL) were treated with aclacinomycin A (60 mg/m2/day for five days) and VP-16-213 (100 mg/m2/day). All were…”
Get more information